tiprankstipranks
Trending News
More News >
Innoveren Scientific (IVRN)
OTHER OTC:IVRN
US Market

Innoveren Scientific (IVRN) Price & Analysis

Compare
12 Followers

IVRN Stock Chart & Stats

$0.03
$0.00(0.00%)
At close: 4:00 PM EST
$0.03
$0.00(0.00%)

IVRN FAQ

What was Innoveren Scientific’s price range in the past 12 months?
Innoveren Scientific lowest stock price was $0.00 and its highest was $0.02 in the past 12 months.
    What is Innoveren Scientific’s market cap?
    Innoveren Scientific’s market cap is $1.30K.
      When is Innoveren Scientific’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Innoveren Scientific’s earnings last quarter?
      Currently, no data Available
      Is Innoveren Scientific overvalued?
      According to Wall Street analysts Innoveren Scientific’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Innoveren Scientific pay dividends?
        Innoveren Scientific does not currently pay dividends.
        What is Innoveren Scientific’s EPS estimate?
        Innoveren Scientific’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Innoveren Scientific have?
        Innoveren Scientific has 3,244,008 shares outstanding.
          What happened to Innoveren Scientific’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Innoveren Scientific?
          Currently, no hedge funds are holding shares in IVRN
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Innoveren Scientific

            H-Cyte, Inc. engages in the design and marketing of proprietary medical devices for commercial use in the United States and Europe. It offers DenerveX device, which provides pain relief from facet joint syndrome. The company was founded by Scott M. W. Haufe and Steven Gorlin on July 30, 2013 and is headquartered in Tampa, FL.
            Similar Stocks
            Company
            Price & Change
            Follow
            Scinai Immunotherapeutics
            PainReform
            NewcelX
            Conduit Pharmaceuticals
            Popular Stocks